Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas

被引:104
作者
Gutmann, DH
Donahoe, J
Brown, T
James, CD
Perry, A
机构
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Pathol, Div Neuropathol, St Louis, MO 63110 USA
[3] Mayo Clin & Mayo Fdn, Div Expt Pathol, Rochester, MN 55905 USA
关键词
glioma; neurofibromatosis; neurofibromin; pilocytic astrocytoma; ras;
D O I
10.1046/j.1365-2990.2000.00258.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The critical role of the neurofibromatosis 1 (NF1) gene as a tumour suppressor has been clearly demonstrated for malignancies arising in NF1 patients. However, little is known about the more common benign tumours, such as the pilocytic astrocytoma. Most NF1-associated astrocytomas are benign and clinically non-progressive, though aggressive tumours are occasionally encountered. In this study, eight pilocytic astrocytomas from six individuals affected with NF1 were analysed for NF1 expression. All eight tumours demonstrated loss of neurofibromin expression by immunohistochemistry, which was confirmed in one case using Western blot analysis. Microsatellite analysis showed loss of a single NF1 allele (LOH) in two of four NF1-associated tumours. These results demonstrate that, in contrast to sporadic astrocytomas, loss of NF1 expression is an important primary genetic event in the pathogenesis of NF1-associated pilocytic astrocytomas.
引用
收藏
页码:361 / 367
页数:7
相关论文
共 37 条
[1]   THE NF1 LOCUS ENCODES A PROTEIN FUNCTIONALLY RELATED TO MAMMALIAN GAP AND YEAST IRA PROTEINS [J].
BALLESTER, R ;
MARCHUK, D ;
BOGUSKI, M ;
SAULINO, A ;
LETCHER, R ;
WIGLER, M ;
COLLINS, F .
CELL, 1990, 63 (04) :851-859
[2]   ABERRANT REGULATION OF RAS PROTEINS IN MALIGNANT-TUMOR CELLS FROM TYPE-1 NEUROFIBROMATOSIS PATIENTS [J].
BASU, TN ;
GUTMANN, DH ;
FLETCHER, JA ;
GLOVER, TW ;
COLLINS, FS ;
DOWNWARD, J .
NATURE, 1992, 356 (6371) :713-715
[3]   Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells [J].
Bollag, G ;
Clapp, DW ;
Shih, S ;
Adler, F ;
Zhang, YY ;
Thompson, P ;
Lange, BJ ;
Freedman, MH ;
McCormick, F ;
Jacks, T ;
Shannon, K .
NATURE GENETICS, 1996, 12 (02) :144-148
[4]   THE BIOLOGICAL AND CLINICAL BEHAVIOR OF PILOCYTIC ASTROCYTOMAS OF THE OPTIC PATHWAYS [J].
BORIT, A ;
RICHARDSON, EP .
BRAIN, 1982, 105 (MAR) :161-187
[5]   A MAJOR SEGMENT OF THE NEUROFIBROMATOSIS TYPE-1 GENE - CDNA SEQUENCE, GENOMIC STRUCTURE, AND POINT MUTATIONS [J].
CAWTHON, RM ;
WEISS, R ;
XU, GF ;
VISKOCHIL, D ;
CULVER, M ;
STEVENS, J ;
ROBERTSON, M ;
DUNN, D ;
GESTELAND, R ;
OCONNELL, P ;
WHITE, R .
CELL, 1990, 62 (01) :193-201
[6]   BENIGN NEUROFIBROMAS IN TYPE-1 NEUROFIBROMATOSIS (NF1) SHOW SOMATIC DELETIONS OF THE NF1 GENE [J].
COLMAN, SD ;
WILLIAMS, CA ;
WALLACE, MR .
NATURE GENETICS, 1995, 11 (01) :90-92
[7]   ABNORMAL REGULATION OF MAMMALIAN P21(RAS) CONTRIBUTES TO MALIGNANT-TUMOR GROWTH IN VONRECKLINGHAUSEN (TYPE-1) NEUROFIBROMATOSIS [J].
DECLUE, JE ;
PAPAGEORGE, AG ;
FLETCHER, JA ;
DIEHL, SR ;
RATNER, N ;
VASS, WC ;
LOWY, DR .
CELL, 1992, 69 (02) :265-273
[8]   Acute presentation of a neurogenic sarcoma in a patient with neurofibromatosis type 1: A pathological and molecular explanation [J].
Feldkamp, MM ;
Lau, N ;
Provias, JP ;
Gutmann, DH ;
Guha, A .
JOURNAL OF NEUROSURGERY, 1996, 84 (05) :867-873
[9]  
Friedman JM, 1999, Neurofibromatosis : phenotype, natural history, and pathogenesis
[10]  
Giordano MJ, 1996, J NEUROSCI RES, V43, P246